The content of this website is intended for United States audiences only.

Global Share

STATUS Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis (AFFIRM)

LAST UPDATED

November 13 2024

Clinicaltrials.gov ID

NCT06051617

OVERVIEW

AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis (AFFIRM)

PROTOCOL SUMMARY

To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.

View More

Participation Requirements

Calendar

Age

18 Years +

Condition

Sex

ALL

Healthy Icon

Healthy Volunteers

No

Study Details

Medical Condition

Primary Biliary Cholangitis

Gender

N/A

Date

September 2023 - July 2029

Study Type

INTERVENTIONAL

Study Phase

PHASE3

Product

Seladelpar, Placebo

Eligibility Information

Inclusion

Inclusion Criteria

  • Subjects must meet the following criteria to be eligible for study participation:
  • 1. Must be at least 18 years old.
  • 2. Must have a confirmed prior diagnosis of PBC
  • 3. Evidence of cirrhosis
  • 4. CP Score A or B
  • 5. Females of reproductive potential must use at least 1 barrier contraceptive and a second effective birth control method during the study and for at least 90 days after the last dose. Male subjects who are sexually active with female partners of reproductive potential must use barrier contraception, and their female partners must use a second effective birth control method during the study and for at least 90 days after the last dose
  • 6. Subjects must be able to comply with the instructions for study drug administration and be able to complete the study schedule of assessments (SOA)
VIEW MORE
Exclusion

Exclusion Criteria

  • Subjects must not meet any of the following criteria to be eligible for study participation:
  • 1. Prior exposure to seladelpar
  • 2. A medical condition other than PBC that, in the Investigator's opinion, would preclude full participation in the study
  • 3. History of liver transplantation or actively listed for cadaveric or planned living donor transplant.
  • 4. Decompensated cirrhosis
  • 5. Evidence of portal vein thrombosis based on imaging at time of Screening by Doppler ultrasound or prior evidence by CT or MRI
  • 6. Hospitalization for liver-related complication within 12 weeks of Screening
  • 7. Laboratory parameters at Screening:
  • 1. ALP ≥10×ULN
  • 2. ALT or AST ≥5×ULN
  • 3. TB ≥5×ULN
  • 4. Platelet count ≤50×10^3/µL
  • 5. Albumin ≤2.8 g/dL
  • 6. Estimated glomerular filtration rate (eGFR) <45 mL/min/1.73 m^2
  • 7. MELD score >12. For subjects on anticoagulation medication, baseline INR determination for MELD score calculation should take anticoagulant use into account, in consultation with the Medical Monitor.
  • 8. Serum alpha-fetoprotein (AFP) >20 ng/mL
  • 9. INR >1.7
  • 8. CP-C cirrhosis
  • 9. History or presence of other concomitant liver diseases
VIEW MORE

Locations

Locations (49)
Recruiting

SCPMG/Kaiser Permanente Los Angeles Medical Center

Los Angeles, California, United States, 90027

Recruiting

California Liver Research Institute

Pasadena, California, United States, 91105

Recruiting

University of California, Davis Medical Center

Sacramento, California, United States, 95817

Will Be Recruiting

California Pacific Medical Center - Sutter Pacific Medical Foundation

San Francisco, California, United States, 94115

Recruiting

Connie Frank Transplant Center at UCSF

San Francisco, California, United States, 94143

Will Be Recruiting

Covenant Metabolic Specialists, LLC

Fort Myers, Florida, United States, 33606

Recruiting

Florida Research Institute

Lakewood Ranch, Florida, United States, 34211

Will Be Recruiting

Schiff Center for Liver Diseases/University of Miami

Miami, Florida, United States, 33136

Will Be Recruiting

Covenant Metabolic Specialists, LLC

Sarasota, Florida, United States, 33912

Will Be Recruiting

Piedmont Atlanta Hospital / Piedmont Transplant Institute

Atlanta, Georgia, United States, 30309

Will Be Recruiting

University of Chicago Medical Center

Chicago, Illinois, United States, 60637

Will Be Recruiting

University Of Iowa Hospitals And Clinics

Iowa City, Iowa, United States, 52242

Recruiting

University of Louisville, Clinical Trials Unit

Louisville, Kentucky, United States, 40202

Will Be Recruiting

University Health System - East Jefferson General Hospital Campus

New Orleans, Louisiana, United States, 70112

Recruiting

Mercy Medical Center

Baltimore, Maryland, United States, 21202

Will Be Recruiting

Gastro One

Germantown, Maryland, United States, 38138

Will Be Recruiting

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Will Be Recruiting

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Will Be Recruiting

Henry Ford Medical Center - Columbus

Detroit, Michigan, United States, 48202

Recruiting

MedStar Health Research Institute / MedStar Georgetown Transplant Institute at Fairfax

Plymouth, Minnesota, United States, 55446

Will Be Recruiting

Ochsner Clinic Foundation

Jefferson City, Missouri, United States, 70121

Will Be Recruiting

Northwell Health Center for Liver Disease and Transplantation

Manhasset, New York, United States, 11030

Recruiting

NYU Langone Health

New York, New York, United States, 10016

Will Be Recruiting

Mount Sinai

New York, New York, United States, 10029

Will Be Recruiting

Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, United States, 27157

Recruiting

University Hosptials Cleveland Medical Center

Cleveland, Ohio, United States, 44106

Will Be Recruiting

Penn State Health Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States, 17033

Will Be Recruiting

OM Research LLC

Lancaster, Pennsylvania, United States, 93536

Will Be Recruiting

Thomas Jefferson University

Philadelphia, Pennsylvania, United States, 19107

Will Be Recruiting

UPMC Center for Liver Diseases

Pittsburgh, Pennsylvania, United States, 15213

Recruiting

The Liver Institute at Methodist Dallas Medical Center

Dallas, Texas, United States, 75203

Will Be Recruiting

University of Texas Southwestern Medical Center, Professional Office Building One

Dallas, Texas, United States, 75235

Will Be Recruiting

Pinnacle Clinical Research, PLLC

San Antonio, Texas, United States, 78229

Will Be Recruiting

Maryview Hospital LLC d/b/a Bon Secours Liver Institute of Hampton Roads

Richmond, Virginia, United States, 23226

Recruiting

VCU Health Clinical Research Services Unit (CRSU)

Richmond, Virginia, United States, 23249

Recruiting

Liver Institute Northwest

Seattle, Washington, United States, 98195

Recruiting

Pusan National University Hospital

Busan, Korea, Republic of, 49241

Recruiting

Kyungpook National University Hospital

Daegu, Korea, Republic of, 41944

Will Be Recruiting

Seoul National University Bundang Hospital

Seongnam, Korea, Republic of, 13620

Will Be Recruiting

Severance Hospital, Yonsei University Health System

Seoul, Korea, Republic of, 3722

Recruiting

Adana City Training and Research Hospital

Adana, Turkey, 1370

Will Be Recruiting

Ege University

Bornova, Turkey, 35100

Will Be Recruiting

Ankara Bilkent City Hospital

Cankaya, Turkey, 06800

Will Be Recruiting

Uludag University Medical Faculty

Gorukle, Turkey, 16059

Will Be Recruiting

Katip Celebi University

Karabağlar, Turkey, 35150

Will Be Recruiting

Kocaeli University Medical Faculty Hospital

Kocaeli, Turkey, 41380

Will Be Recruiting

Rize Recep Tayyip Erdogan University Training and Research Hospital

Maltepe, Turkey, 34840

Will Be Recruiting

Mersin Universitesi Tip Fakultesi Hastanesi

Mersin, Turkey, 33169

Recruiting

Marmara University Pendik Training and Research Hospital

Pendik, Turkey, 34899